AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of notch signaling

被引:28
作者
Huang, YP
Kim, Y
Li, ZB
Fomenkov, T
Fomenkov, A
Ratovitski, EA
机构
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Surg, Baltimore, MD 21205 USA
关键词
p63; RNA processing; ABBP1; proteasome; RNA polymerase II; RACK1; stratifin;
D O I
10.4161/cc.4.10.2086
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p63, the major regulator of epithelial development/differentiation, is mutated in human ectodermal dysplasias, such as ankyloblepharon, ectodermal dysplasia and clefting (AEC). We recently identified that p63 a physically associated with mRNA processing/ splicing proteins. We previously showed that p63 mutations mapped to the sterile alpha-motif led to disruption of these interactions and modulated an aberrant splicing of keratinocyte growth factor receptor contributing into molecular mechanism underlying AEC phenotype. To further investigate the molecular mechanisms associated with AEC syndrome we established the cellular model for this disorder by stable introduction of mutated allele [L514F] of p63 alpha into immortalized keratinocyte cells. We showed that mutated Delta Np63 alpha mediated an aberrant splicing of its own p63 mRNA transcript, which in turn led to accumulation of proteasome-resistant C-terminal truncated p63. The truncated p63 failed to associate with the C-terminal domain of RNA polymerase II through SRA4 protein and, therefore affected keratinocyte proliferation, differentiation and survival and may strongly contribute to AEC phenotype.
引用
收藏
页码:1440 / 1447
页数:8
相关论文
共 37 条
[1]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[2]   Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome [J].
Celli, J ;
Duijf, P ;
Hamel, BCJ ;
Bamshad, M ;
Kramer, B ;
Smits, APT ;
Newbury-Ecob, R ;
Hennekam, RCM ;
Van Buggenhout, G ;
van Haeringen, B ;
Woods, CG ;
van Essen, AJ ;
de Waal, R ;
Vriend, G ;
Haber, DA ;
Yang, A ;
McKeon, F ;
Brunner, HG ;
van Bokhoven, H .
CELL, 1999, 99 (02) :143-153
[3]   A CTD function linking transcription to splicing [J].
Corden, JL ;
Patturajan, M .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (11) :413-416
[4]   p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes [J].
Dohn, M ;
Zhang, SZ ;
Chen, XB .
ONCOGENE, 2001, 20 (25) :3193-3205
[5]   Bilateral nephroblastoma in familial Hay-Wells syndrome associated with familial reticulate pigmentation of the skin [J].
Drut, R ;
Pollono, D ;
Drut, RM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 110 (02) :164-169
[6]   Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63 [J].
Duijf, PHG ;
Vanmolkot, KRJ ;
Propping, P ;
Friedl, W ;
Krieger, E ;
McKeon, F ;
Dötsch, V ;
Brunner, HG ;
van Bokhoven, H .
HUMAN MOLECULAR GENETICS, 2002, 11 (07) :799-804
[7]   The Notch target genes Hey1 and Hey2 are required for embryonic vascular development [J].
Fischer, A ;
Schumacher, N ;
Maier, M ;
Sendtner, M ;
Gessler, M .
GENES & DEVELOPMENT, 2004, 18 (08) :901-911
[8]   p63α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome [J].
Fomenkov, A ;
Huang, YP ;
Topaloglu, O ;
Brechman, A ;
Osada, M ;
Fomenkova, T ;
Yuriditsky, E ;
Trink, B ;
Sidransky, D ;
Ratovitski, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23906-23914
[9]  
FORMENKOV A, 2004, CELL CYCLE, V3, P1285
[10]   Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains [J].
Ghioni, P ;
Bolognese, F ;
Duijf, PHG ;
van Bokhoven, H ;
Mantovani, R ;
Guerrini, L .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (24) :8659-8668